Results 211 to 220 of about 183,686 (358)

Diagnostic utility and pitfalls of human T-lymphotropic virus serology in adult T-cell leukemia/lymphoma: evidence from a 25-year pathology-based nonendemic cohort. [PDF]

J Pathol Clin Res
Yuan CT, Sun LY, Chuang SS, Karube K, Yang HB, Lee SH, Wang RC, Chang KC, Kao CJ, Huang HH, Chou WC.   +10 more
europepmc   +1 more source

Low Correlation of Serology with Detection of Chlamydia trachomatis by Ligase Chain Reaction and Antigen EIA [PDF]

, 2000
Holger F. Rabenau, E. M. Kohler, Marjolein Peters, Hans Wilhelm Doerr, Bernard Weber   +4 more
openalex   +1 more source

Dengue diagnosis in an endemic area of Peru: Clinical characteristics and positive frequencies by RT-PCR and serology for NS1, IgM, and IgG [PDF]

, 2019
Carlos Palomares-Reyes, Wilmer Silva-Caso, Luís J. del Valle, Miguel Ángel Aguilar-Luis, Claudia Weilg, Johanna Martins-Luna, Adriana Viñas-Ospino, Luciana Stimmler, Naysha Mallqui Espinoza, Ronald Aquino-Ortega, Walter Espinoza Espíritu, Erika Misaico, Juana del Valle-Mendoza   +12 more
openalex   +1 more source

Clinical progress note: Rubella

Journal of Hospital Medicine, EarlyView.
Abstract Rates of rubella infection and congenital rubella syndrome decreased significantly since the introduction of the rubella vaccine in 1969. Endemic rubella was declared eliminated in the United States in 2004, and since 2012, all rubella cases in the United States have been associated with infections acquired abroad.
Adam E. Gailani, Walter Dehority, Sophie E. Katz   +2 more
wiley   +1 more source

Role of serology in the COVID-19 pandemic

Clinical Infectious Diseases, 2020
S. Stowell, J. Guarner
semanticscholar   +1 more source

Clinical progress note: Hepatitis A virus

Journal of Hospital Medicine, EarlyView.
Abstract Despite a decline in hepatitis A virus (HAV) incidence following vaccine introduction, HAV remains a public health concern in the United States. Recent multi‐state outbreaks have demonstrated that HAV can re‐emerge and highlight inequities in vaccine coverage or access, outbreak response, and in those with social or health risk factors ...
James M. McCluskey III, Robyn A. Bockrath, Ravi Jhaveri   +2 more
wiley   +1 more source

Impact of obesity on COVID-19 CoronaVac and ChAdOx1-S vaccine efficacy. [PDF]

BMC Infect Dis
Cortez MV, Martins A, Nascimento J, Chui FMDS, Rodrigues MGA, Bastos T, Lemos SM, Honorato E, Gomes E, Abreu-Netto RL, Fernandes S, Silva-Neto AV, Sachett A, Silva BM, Mouta GS, Cordeiro JSM, Baía-da-Silva DC, Brito-Sousa JD, Pessoa KP, Monteiro W, Naveca F, Sampaio V, Almeida-Val F, Melo G, Mourão MP, Lacerda M.   +25 more
europepmc   +1 more source

Serological [PDF]

, 2020
openaire   +1 more source

Reshaping study design for faster extrapolation‐based drug approval in pediatric inflammatory bowel diseases: An ESPGHAN–NASPGHAN position paper

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Children with inflammatory bowel diseases (IBD) have limited access to the available advanced therapies, given the lengthy gap between adult and pediatric approval. We aimed to review key hurdles for pediatric trials and recommend practical solutions.
Dan Turner, Amit Assa, Mikkel Malham, Shira Yuval Bar‐Asher, Carla Rayan, Jeffrey S. Hyams, Holm H. Uhlig, Brad Pasternak, David C. Wilson, Hilary K. Michel, Lissy de Ridder, Eric Zuckerman, Marina Aloi, Peter Szitanyi, Marla C. Dubinsky, Anne M. Griffiths, Roberto Saldana, Javier Martín‐de‐Carpi, Eytan Wine, Richard K. Russell, Jeremy Adler, Joseph Picoraro   +21 more
wiley   +1 more source

Added Value of Nucleic Acid Testing in Blood Banks: A 15-Year Retrospective Study from India. [PDF]

Cureus
Pathak S, Singh S, Chakraborty T, Kaushik S, Dubey R.   +4 more
europepmc   +1 more source